Fundamentals in Health Economics

November 20-22, 2017, Basel, Switzerland

deadline for registration: November 4, 2017

Course outline

This course intends to provide the participants with an understanding of the key principles and methodological concepts of health economics. The role of health-economic thinking in the drug development process is addressed. Two group exercises will complement lectures and discussions.

Learning Outcomes

At the end of the course, the participants will

  • Understand the fundamental concepts of health economics.
  • Understand key principles of health economic evaluation.
  • Be able to assess and appraise a published health economic analysis according to guidelines and checklists.
  • Understand the importance of health economic/pharmacoeconomic methods and concepts for the drug development process, clinical trials, and post-marketing surveillance.
  • Understand how policy makers set priorities in health care and how health economic evaluations support this process and understand the importance of health technology assessment in different health care systems.
  • Understand rational choice and priority setting using economic evaluation.

 

Faculty

Prof. Thomas D. Szucs, MD MPH MBA LLM

Prof Matthias Schwenkglenks, PhD MPH

Zanfina Ademi, Pharm, MPH, PhD

 

Credits

2 ECTS

125 Points FPH Spital , GSASA

 Fee

1800 CHF
900 CHF for academia and non for profit organisations

The fees include meeting materials, lunch, coffee